Inventor · Mendham, NJ, US

David M. Goldenberg

383Patents
47h-index
52Co-inventors
93Inventor score

Filing activity: May 6, 1991 → Jun 28, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6306393A Immunotherapy of B-cell malignancies using anti-CD22 antibodies Human Necessities 388 Expired
US6183744A Immunotherapy of B-cell malignancies using anti-CD22 antibodies Human Necessities 216 Expired
US7151164B2 Anti-CD20 antibodies and fusion proteins thereof and methods of use Chemistry; Metallurgy 201 Expired
US6653104B2 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells Chemistry; Metallurgy 194 Expired
US5716595A Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments Human Necessities 180 Expired
US7312318B2 Internalizing anti-CD74 antibodies and methods of use Chemistry; Metallurgy 168 Expired
US7074403B1 Immunotherapy of autoimmune disorders using antibodies which target B-cells Chemistry; Metallurgy 138 Expired
US7521056B2 Stably tethered structures of defined compositions with multiple functions or binding specificities Chemistry; Metallurgy 134 Active
US7527787B2 Multivalent immunoglobulin-based bioactive assemblies Chemistry; Metallurgy 133 Active
US7238785B2 RS7 antibodies Chemistry; Metallurgy 132 Expired
US6036344A Secure check processing system and method Physics 130 Expired
US7534866B2 Methods and compositions for generating bioactive assemblies of increased complexity and uses Chemistry; Metallurgy 123 Active
US5525338A Detection and therapy of lesions with biotin/avidin conjugates Human Necessities 118 Expired
US7550143B2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses Chemistry; Metallurgy 115 Active
US7999083B2 Immunoconjugates with an intracellularly-cleavable linkage Emerging Cross-Sectional Technologies 113 Active
US7906121B2 Methods and compositions for generating bioactive assemblies of increased complexity and uses Chemistry; Metallurgy 112 Active
US7666400B2 PEGylation by the dock and lock (DNL) technique Chemistry; Metallurgy 111 Active
US7591994B2 Camptothecin-binding moiety conjugates Emerging Cross-Sectional Technologies 110 Active
US6395276B1 Immunotoxins directed against malignant cells Chemistry; Metallurgy 103 Expired
US5922302A Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates Human Necessities 99 Expired
US5698178A Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype Chemistry; Metallurgy 98 Expired
US7772373B2 Internalizing anti-CD74 antibodies and methods of use Chemistry; Metallurgy 97 Active
US7282567B2 Monoclonal antibody hPAM4 Chemistry; Metallurgy 89 Expired
US8119101B2 Anti-CD74 immunoconjugates and methods of use Physics 87 Active
US8080250B1 Immunoconjugates with an intracellularly-cleavable linkage Emerging Cross-Sectional Technologies 83 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.